QUALASEPT PHARMAXO HOLDINGS LIMITED

Company number 06981369

Date	Type	Description	View / Download
04 Jan 2024	AA	Full accounts made up to 31 December 2022	(23 pages)
02 Jan 2024	TM01	Termination of appointment of Andrew John Alsop as a director on 31 December 2023	(1 page)
02 Oct 2023	AP01	Appointment of Mr Andrew Robinson as a director on 1 August 2023	(2 pages)
16 Aug 2023	CS01	Confirmation statement made on 5 August 2023 with updates	(5 pages)
14 Apr 2023	TM01	Termination of appointment of Andrew Charles Davies as a director on 31 March 2023	(1 page)
15 Feb 2023	TM02	Termination of appointment of Katherine Hamilton Jennings as a secretary on 13 February 2023	(1 page)
07 Oct 2022	AA	Full accounts made up to 31 December 2021	(23 pages)
08 Aug 2022	CS01	Confirmation statement made on 5 August 2022 with no updates	(3 pages)
14 Apr 2022	TM01	Termination of appointment of Mark Edward Roderick as a director on 14 April 2022	(1 page)
08 Apr 2022	AP01	Appointment of Mr Ian Stuart Muir as a director on 5 April 2022	(2 pages)
07 Apr 2022	TM01	Termination of appointment of Christopher James Fountain as a director on 31 March 2022	(1 page)
02 Feb 2022	AA	Full accounts made up to 30 April 2021	(22 pages)
22 Sep 2021	AA01	Current accounting period shortened from 30 April 2022 to 31 December 2021	(1 page)
10 Aug 2021	CS01	Confirmation statement made on 5 August 2021 with updates	(5 pages)
10 Aug 2021	AP03	Appointment of Katherine Hamilton Jennings as a secretary on 12 July 2021	(2 pages)
02 Jul 2021	TM01	Termination of appointment of Maria Ann Watt as a director on 18 June 2021	(1 page)
26 Jan 2021	AA	Full accounts made up to 30 April 2020	(21 pages)
05 Aug 2020	CS01	Confirmation statement made on 5 August 2020 with updates	(5 pages)
28 Jan 2020	CH01	Director's details changed for Mr Christopher Dean Watt on 1 July 2019	(2 pages)
28 Jan 2020	CH01	Director's details changed for Mrs Maria Ann Watt on 1 July 2019	(2 pages)
05 Sep 2019	AA	Full accounts made up to 30 April 2019	(20 pages)
02 Sep 2019	PSC05	Change of details for Qualasept Holdings Limited as a person with significant control on 2 September 2019	(2 pages)
05 Aug 2019	CS01	Confirmation statement made on 5 August 2019 with updates	(5 pages)
04 Jul 2019	AP01	Appointment of Mark Edward Roderick as a director on 18 June 2019	(2 pages)
04 Jul 2019	AP01	Appointment of Andrew Charles Davies as a director on 18 June 2019	(2 pages)